Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ORPH

Orphazyme A/S (ORPH) Stock Price, News & Analysis

Orphazyme A/S logo

About Orphazyme A/S Stock (NASDAQ:ORPH)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.57
$2.21
52-Week Range
N/A
Volume
941,400 shs
Average Volume
1.37 million shs
Market Capitalization
$30.72 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ORPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Orphazyme A/S and its competitors with MarketBeat's FREE daily newsletter.

ORPH Stock News Headlines

The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
See More Headlines

ORPH Stock Analysis - Frequently Asked Questions

Orphazyme A/S (ORPH) raised $100 million in an IPO on Tuesday, September 29th 2020. The company issued 7,600,000 shares at a price of $13.13 per share. BofA Securities, Cowen and Guggenheim Securities acted as the underwriters for the IPO and Danske Markets was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Orphazyme A/S investors own include AMC Entertainment (AMC), Digital World Acquisition (DWAC), NIO (NIO), Biora Therapeutics (BIOR), SNDL (SNDL), Tesla (TSLA) and Brigham Minerals (MNRL).

Company Calendar

Today
7/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ORPH
Fax
N/A
Employees
141
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$2.74 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$30.72 million
Optionable
Not Optionable
Beta
1.68
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:ORPH) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners